- Home
- III vs PRME Comparison
III vs PRME Comparison
Compare III & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- III
- PRME
- Stock Information
- Founded
- III 2006
- PRME 2019
- Country
- III United States
- PRME United States
- Employees
- III N/A
- PRME N/A
- Industry
- III Professional Services
- PRME Medicinal Chemicals and Botanical Products
- Sector
- III Consumer Discretionary
- PRME Health Care
- Exchange
- III Nasdaq
- PRME Nasdaq
- Market Cap
- III 227.5M
- PRME 191.7M
- IPO Year
- III 2007
- PRME 2022
- Fundamental
- Price
- III $4.81
- PRME $4.27
- Analyst Decision
- III Buy
- PRME Buy
- Analyst Count
- III 1
- PRME 6
- Target Price
- III $5.50
- PRME $9.38
- AVG Volume (30 Days)
- III 227.1K
- PRME 5.0M
- Earning Date
- III 08-06-2025
- PRME 08-04-2025
- Dividend Yield
- III 3.72%
- PRME N/A
- EPS Growth
- III N/A
- PRME N/A
- EPS
- III 0.16
- PRME N/A
- Revenue
- III $242,899,000.00
- PRME $3,846,000.00
- Revenue This Year
- III N/A
- PRME $104.12
- Revenue Next Year
- III $5.08
- PRME $108.24
- P/E Ratio
- III $30.91
- PRME N/A
- Revenue Growth
- III N/A
- PRME 550.76
- 52 Week Low
- III $2.95
- PRME $1.11
- 52 Week High
- III $5.28
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- III 50.05
- PRME 80.29
- Support Level
- III $4.98
- PRME $2.28
- Resistance Level
- III $5.28
- PRME $4.83
- Average True Range (ATR)
- III 0.17
- PRME 0.46
- MACD
- III 0.00
- PRME 0.21
- Stochastic Oscillator
- III 37.33
- PRME 84.52
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.